In 2021, the rate of cannabis and psychedelic use among young adults between 19-30 years old reached an all-time high since the usage trends first became monitored in 1988, according to a new study.
On Monday, the National Institutes of Health (NIH) released new data from a Monitoring the Future (MTF) panel study.
MTF is a component of the NIH funded by the National Institute on Drug Abuse (NIDA) specializing in surveys related to alcohol and drugs. The analyses it undertakes are conducted by scientists at the University of Michigan’s Institute for Social Research in Ann Arbor.
News: Marijuana and hallucinogen use among young adults reached all-time high in 2021 https://t.co/IJtOQpH4EL
— NIH (@NIH) August 22, 2022
The NIH is the primary American medical research agency and part of the U.S. Department of Health and Human Services.
The data for the 2021 survey was collected between April and October that year and revealed some notable information.
According to the MTF study, past-year, past-month and daily cannabis use among young adults reached a record high in 2021 that had never been observed since the usage trends first became monitored in 1988.
The researchers found that the percentage of young adults who reported using pot that year shot up to 43 per cent, a substantial increase from 34 per cent in 2016 and 29 per cent in 2011. Past-month use recorded during that time period also saw a record high at 29 per cent, up from 21 per cent in 2016 and 17 per cent in 2011. Lastly, daily use during 2021 was disclosed by 11 per cent of young adults, displaying an increase from eight per cent in 2016 and six per cent in 2011.
Past-month prevalence of cannabis vaping recorded has also had a 100 per cent increase from 6 per cent in 2017 to 12 per cent in 2021.
The scientists from U Michigan say that the rate of past-year psychedelic use had been relatively stable for many years until 2020 when reports of usage started increasing rapidly.
Eight percent of young adults reported experimentation with psychedelics in 2021, a record high since the category became monitored in the late 1980s. In comparison, only 5 per cent of young adults reported use in 2016 and merely 3 per cent did in 2011.
Types of psychedelic substances that survey participants reported using include psilocybin mushrooms, LSD, mescaline, MDMA and peyote. The only substance that saw a significant decrease in usage was MDMA (reported by 5 per cent of young adults between 2016-2020 and only 3 per cent in 2021).